Browsing by Title :

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 36101 to 36120 of 77143

This table browses all dspace content
Issue DateTitleJournal Title
2006Phase II Study of Cisplatin Combined with Weekly Gemcitabine in the Treatment of Patients with Metastatic Pancreatic CarcinomaPANCREATOLOGY
2012Phase II study of cisplatin with irinotecan as induction chemotherapy followed by chemoradiotherapy for unresectable stage III non-small cell lung cancerANTICANCER RESEARCH
2008Phase II study of combination chemotherapy of 5-fluorouracil, low-dose leucovorin, and oxaliplatin (FLOX regimen) in pretreated advanced gastric cancer ANNALS OF ONCOLOGY
2021Phase II study of DHP107 (oral paclitaxel) in the first-line treatment of HER2-negative recurrent or metastatic breast cancer (OPTIMAL study) THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
2023Phase II study of durvalumab and tremelimumab with front-line neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer: primary analysis in the original cohort of KGOG3046/TRU-D JOURNAL FOR IMMUNOTHERAPY OF CANCER
2022Phase II study of durvalumab monotherapy in patients with previously treated microsatellite instability-high/mismatch repair-deficient or POLE-mutated metastatic or unresectable colorectal cancerINTERNATIONAL JOURNAL OF CANCER
2007Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinibJOURNAL OF CLINICAL ONCOLOGY
2006Phase II study of gemcitabine and cisplatin in advanced biliary tract cancerJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2015Phase II study of gemcitabine and vinorelbine as second- or third-line therapy in patients with primary refractory or platinum-resistant recurrent ovarian and primary peritoneal cancer by the Korean Cancer Study Group (KCSG)_KCSG GY10-10GYNECOLOGIC ONCOLOGY
2003Phase II Study of Gemcitabine and Vinorelbine as Second-Line Chemotherapy in Non-Small Cell Lung Cancer CANCER RESEARCH AND TREATMENT
2022Phase II study of gemcitabine with oxaliplatin (GEMOX) in heavily treated patients with advanced hepatocellular carcinoma after failure of sorafenib treatment (PEACH)JOURNAL OF CLINICAL ONCOLOGY
2022Phase II study of olaparib plus durvalumab with or without bevacizumab (MEDIOLA): Final analysis of overall survival in patients with non-germline BRCA-mutated platinum-sensitive relapsed ovarian cancerANNALS OF ONCOLOGY
2010Phase II study of preoperative chemoradiotherapy (CRT) with irinotecan plus S-1 in locally advanced rectal cancerRADIOTHERAPY AND ONCOLOGY
2022Phase II study of sitravatinib in combination with tislelizumab in patients with advanced biliary tract cancer who have failed to at least 1 prior systemic treatment: Trial in progressJOURNAL OF CLINICAL ONCOLOGY
2011Phase II study of sunitinib as second-line treatment for advanced gastric cancer INVESTIGATIONAL NEW DRUGS
2012Phase II study of the safety and efficacy of temsirolimus in East Asian patients with advanced renal cell carcinomaJAPANESE JOURNAL OF CLINICAL ONCOLOGY
2009Phase II study of transarterial holmium-166-chitosan complex treatment in patients with a single, large hepatocellular carcinomaONCOLOGY
2015Phase II study of trastuzumab in combination with S-1 and cisplatin in the first-line treatment of human epidermal growth factor receptor HER2-positive advanced gastric cancerCANCER CHEMOTHERAPY AND PHARMACOLOGY
2012Phase II study of weekly docetaxel and fixed dose rate gemcitabine in patients with previously treated advanced soft tissue and bone sarcoma.CANCER CHEMOTHERAPY AND PHARMACOLOGY
2022Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma®) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+ metastatic breast cancer (KCSG BR 18-14/KM10B)BREAST

Browse

Links